Get Your Personalized Supplement StackSupplement Stack Quiz

Applied Nitric Oxide Matrix

Also known as: Nitric oxide, NO donors, Nitric oxide precursors, L-arginine, L-citrulline, Applied Nitric Oxide Matrix, Nitric Oxide Precursors

Overview

Nitric oxide (NO) is a naturally occurring gaseous signaling molecule produced endogenously from L-arginine by nitric oxide synthase enzymes. It plays a crucial role in the cardiovascular, nervous, and immune systems. Supplements marketed as "Applied Nitric Oxide Matrix" or similar formulations are not a single chemical entity but rather proprietary blends designed to enhance the body's natural production of NO, typically by providing precursors like L-arginine or L-citrulline. The primary goal of these supplements is to improve vasodilation and blood flow, which can impact exercise performance, cardiovascular health, and potentially respiratory function. While extensive research exists on the biology of nitric oxide and the clinical applications of inhaled NO (used in specific medical settings for conditions like acute respiratory distress), the evidence for oral NO supplements is more varied and less conclusive. These supplements aim to leverage NO's short-lived, local signaling properties to achieve systemic benefits, though their effectiveness depends heavily on the specific formulation and the body's ability to convert precursors into active NO.

Benefits

The benefits of nitric oxide modulation are diverse, though the evidence quality varies significantly between inhaled NO and oral NO precursor supplements. Inhaled nitric oxide (iNO) has strong evidence for improving oxygenation in acute respiratory distress syndrome (ARDS), though it does not significantly reduce mortality. For infants with acute bronchiolitis, iNO may modestly reduce hospital stay duration by approximately 11 hours, but this evidence is of low certainty. Exercise training is known to increase endogenous NO and nitrate/nitrite levels, which correlates with improved vascular function and exercise capacity, as supported by systematic reviews and meta-analyses. Oral NO precursors are theorized to offer similar benefits by enhancing blood flow and nutrient delivery to muscles, potentially improving exercise performance and recovery. However, direct, high-quality evidence specifically for branded oral 'Nitric Oxide Matrix' supplements is often lacking, with most research focusing on individual precursors like L-arginine or L-citrulline. While NO influences immune response, inflammation, and neurotransmission, the clinical benefits of oral supplementation in these areas are not well-established. The most robust benefits are seen in clinical settings with inhaled NO for specific respiratory conditions, and in the context of exercise-induced NO increases for vascular health.

How it works

Nitric oxide (NO) primarily functions by activating soluble guanylate cyclase (sGC) within cells. This activation leads to an increase in cyclic guanosine monophosphate (cGMP), which in turn triggers the relaxation of smooth muscle cells, resulting in vasodilation (widening of blood vessels). This vasodilation is key to NO's role in regulating blood pressure and improving blood flow. Beyond its cardiovascular effects, NO also modulates mitochondrial respiration, influencing cellular energy production, and plays a role in immune cell function and neurotransmission. Oral NO supplements typically provide precursors such as L-arginine or L-citrulline. L-arginine is directly converted to NO by nitric oxide synthase (NOS) enzymes, while L-citrulline is recycled back to L-arginine, thereby increasing the substrate available for NO production. The effectiveness of these supplements depends on their absorption and the efficiency of these enzymatic conversion pathways.

Side effects

The safety profile of nitric oxide varies significantly depending on the form of administration. Inhaled nitric oxide (iNO), used in clinical settings, is generally safe but requires careful monitoring due to potential side effects such as hypotension (low blood pressure) and headache. A more serious, though uncommon, side effect of iNO is methemoglobinemia, a condition where hemoglobin is unable to release oxygen effectively. Rare but severe side effects include profound hypotension and rebound pulmonary hypertension upon abrupt discontinuation. For oral nitric oxide precursor supplements, side effects are generally mild and less frequent. Common side effects include gastrointestinal discomfort, such as nausea or diarrhea. Allergic reactions are uncommon. Due to their vasodilatory effects, oral NO precursors should be used with caution alongside other vasodilators, particularly PDE5 inhibitors (e.g., sildenafil), as this combination can lead to additive hypotensive effects. Contraindications for oral supplements are generally not as strict as for iNO, but individuals with severe hypotension or certain cardiovascular conditions should consult a healthcare professional. Special populations, such as infants and critically ill patients, require precise dosing and continuous monitoring when receiving iNO.

Dosage

The dosage for nitric oxide-enhancing supplements varies significantly depending on the specific precursor and formulation, as there is no standardized dose for a general "Applied Nitric Oxide Matrix." For inhaled nitric oxide (iNO) in clinical settings, typical concentrations range from 5 to 20 parts per million (ppm), administered continuously. For oral NO precursors, common dosages are often in the gram range. For example, L-arginine is frequently dosed between 3 to 6 grams per day, while L-citrulline can range from 3 to 9 grams per day. These dosages may be split throughout the day or taken pre-workout. The maximum safe dose depends on the specific ingredient, as high doses of NO donors can lead to hypotension and other toxicities. Oral supplements are typically taken daily, while iNO is administered acutely in hospital settings. Absorption and bioavailability can be influenced by the supplement's form (e.g., powder, capsule) and the presence of co-factors like Vitamin C or folate, which may support endogenous NO synthesis. It is crucial to follow the manufacturer's recommendations for specific branded products, as formulations and concentrations can differ.

FAQs

Is Applied Nitric Oxide Matrix the same as inhaled nitric oxide?

No, they are different. Inhaled nitric oxide is a medical gas used in hospitals for specific conditions. 'Applied Nitric Oxide Matrix' is a dietary supplement, likely containing precursors to help your body produce more nitric oxide naturally.

Does it improve exercise performance?

Evidence suggests that nitric oxide precursors can improve blood flow and endurance, potentially enhancing exercise performance. However, direct evidence for this specific branded 'Matrix' is often limited, with most research focusing on individual ingredients like L-arginine or L-citrulline.

Is it safe for long-term use?

Oral nitric oxide precursors are generally considered safe for long-term use at recommended dosages. Inhaled nitric oxide, however, is for short-term clinical use only. Always consult a healthcare professional for personalized advice.

How quickly do benefits appear?

Inhaled nitric oxide has immediate effects. For oral supplements, benefits typically develop over several weeks of consistent use as your body's nitric oxide production gradually increases.

When should it be taken?

Oral nitric oxide supplements are often taken daily, sometimes before exercise to maximize blood flow during workouts. Inhaled nitric oxide is administered in a hospital setting under medical supervision.

Research Sources

https://pubmed.ncbi.nlm.nih.gov/21372277/ – This systematic review and meta-analysis of randomized controlled trials (RCTs) found that inhaled nitric oxide (iNO) improves oxygenation in adults and children with Acute Respiratory Distress Syndrome (ARDS) but does not reduce mortality. The study highlights the heterogeneity across trials and the lack of a survival benefit despite physiological improvements.
https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2022.953912/full – This systematic review and meta-analysis investigated the effects of exercise training on nitric oxide (NOx) levels. It concluded that exercise increases endogenous NOx levels, which is associated with improved vascular function. The study noted heterogeneity in exercise types and NO measurement methods but provided moderate to high-quality evidence for the link between exercise and NO-mediated vascular benefits.
https://onlinelibrary.wiley.com/doi/full/10.1002/ppul.26767 – This systematic review and meta-analysis of RCTs evaluated the use of inhaled nitric oxide (iNO) in infants with acute bronchiolitis. The findings suggested that iNO might reduce the duration of hospital stay by approximately 11 hours, though the evidence certainty was low due to small sample sizes and potential biases in the included studies.